CI

CDTI Innovación's INNVIERTE program

Europe, Madrid, Spain, Madrid

Description

CDTI Innovación's INNVIERTE program is part of the Spanish Science, Technology and Innovation Strategy.

Investor Profile

CDTI Innovación's INNVIERTE program has backed more than 18 startups, with 11 new investments in the last 12 months alone. The firm has led 7 rounds, about 39% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Seed, Grant rounds (top funding stages).
  • Majority of deals are located in Spain.
  • Strong thematic focus on Biotechnology, Health Care, Medical.
  • Led 7 rounds in the past year.

Stage Focus

  • Series Unknown (44%)
  • Seed (33%)
  • Grant (11%)
  • Series B (6%)
  • Series A (6%)

Country Focus

  • Spain (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Manufacturing
  • Information Technology
  • Sustainability
  • Software
  • Life Science
  • Medical Device
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does CDTI Innovación's INNVIERTE program frequently co-invest with?

Co-Investments: 1
Quest Diagnostics
North America, New Jersey, United States, Secaucus
Co-Investments: 1
Clave
Europe, Navarra, Spain, Pamplona
Co-Investments: 2
A
Europe, Luxembourg, Luxembourg, Münsbach
Co-Investments: 1
European Innovation Council
Europe, Brussels Hoofdstedelijk Gewest, Belgium, Brussels
Co-Investments: 1
Co-Investments: 1
Fitalent
Europe, Madrid, Spain, Madrid
Co-Investments: 1
CTI Life Sciences Fund
North America, Quebec, Canada, Montréal
Co-Investments: 1
NC
Europe, Catalonia, Spain, Barcelona
Co-Investments: 4
Inveready
Europe, Catalonia, Spain, Barcelona
Co-Investments: 3

What are some of recent deals done by CDTI Innovación's INNVIERTE program?

Ona Therapeutics

Barcelona, Catalonia, Spain

Ona Therapeutics is focused on the discovery and development of therapeutic biologics to treat metastatic cancer.

BiotechnologyHealth CareLife Science
Series UnknownOct 9, 2025
Amount Raised: $11,563,461
Nanoligent

Barcelona, Catalonia, Spain

Nanoligent aim is the research and development to clinical phases of innovative cancer treatments based on protein nanoparticles.

BiotechnologyNanotechnologyOncologyPharmaceutical
Series AOct 6, 2025
Amount Raised: $14,058,304
X1 Wind

Barcelona, Catalonia, Spain

X1 Wind is a disruptive floating platform developing a floating wind platform for deep waters.

CleanTechEnvironmental ConsultingRenewable Energy
Series UnknownSep 26, 2025
Amount Raised: $472,971
Ability Pharmaceuticals

Barcelona, Catalonia, Spain

Ability Pharmaceuticals is a drug discovery and development company.

BiotechnologyHealth CarePharmaceutical
Series UnknownSep 17, 2025
ARTHEx Biotech

Valencia, Comunidad Valenciana, Spain

AntagomiR oligonucleotides to treat Myotonic Dystrophy patients.

Biotechnology
Series BSep 17, 2025
Amount Raised: $40,640,000
Integra Therapeutics

Barcelona, Catalonia, Spain

Integra Therapeutics is a developer of next generation of gene editing tools to cure diseases.

BiotechnologyGeneticsHealth Care
SeedSep 8, 2025
Amount Raised: $12,541,948
Neboda

Vigo, Galicia, Spain

Neboda is a science and technology that aims to transform agriculture into a more sustainable, competitive, and appealing business

AgricultureFarmingRoboticsSustainability
SeedJul 21, 2025
Amount Raised: $2,139,786
Next-Gen Leather

Madrid, Madrid, Spain

Next-Gen Leather is a developer of a biotechnological process system designed to produce biodegradable leather.

Manufacturing
GrantJun 25, 2025
Amount Raised: $1,102,017
Cocunat

Barcelona, Catalonia, Spain

Cocunat is a natural and 100% toxic free cosmetics brand.

CosmeticsE-Commerce
Series UnknownJun 24, 2025
Amount Raised: $1,046,211
Aortyx

Barcelona, Catalonia, Spain

The ultimate solution for aortic diseases

BiotechnologyLife Science
Series AJun 12, 2025
Amount Raised: $15,950,401